Tech Company Financing Transactions
Enable Injections Funding Round
Enable Injections closed a $215 million Series C funding round on 2/4/2022. Investors included Magnetar Capital Return, Cincinnati Children's Hospital Medical Center and CincyTech.
Transaction Overview
Company Name
Announced On
2/4/2022
Transaction Type
Venture Equity
Amount
$215,000,000
Round
Series C
Investors
Proceeds Purpose
This financing will provide additional resources to onboard important new pharma partner programs and accelerate our commercialization programs and platforms with existing pharma partners.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2863 East Sharon Rd.
Cincinnati, OH 45241
USA
Cincinnati, OH 45241
USA
Phone
Website
Email Address
Overview
Enable Injections develops and manufactures devices that allow patient self-administration of high volume/viscosity drugs. The Enable Injector technology is a discrete body-worn device that provides a comfortable injection experience allowing the patient to continue with normal daily activities.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Hooven
Chief Financial Officer
Timothy Flaherty
VP - Administration
Susan Spies
VP - Manufacturing
John Love
VP - Operations
Eileen Rogers
VP - R & D
Matthew Huddleston
VP - Regulatory Affairs
Dominick Villani
Browse more venture capital transactions:
Prev: 2/4/2022: Snapfix venture capital transaction
Next: 2/4/2022: Tuum venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs